(Q24241518)

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Reboxetine may be helpful in the treatment of amphetamine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

The nature, time course and severity of methamphetamine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Self detoxication by amphetamine dependent patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Amphetamine withdrawal and sleep disturbance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

A systematic review of cognitive and behavioural therapies for methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Psychometric evaluation of the Amphetamine Cessation Symptom Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Implications of chronic methamphetamine use: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Methamphetamine abstinence syndrome: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Methamphetamine users in the psychiatric emergency services: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Neurocognitive effects of methamphetamine: a critical review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

A simple test of cocaine craving and related responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003021.PUB2

Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.

21 January 2018

1 reference

12 December 2020

Treatment for amphetamine withdrawal.

1 reference

12 December 2020

Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions

1 reference

12 December 2020

Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat

1 reference

12 December 2020

Bupropion for amphetamine withdrawal syndrome.

1 reference

12 December 2020

The pharmacologic profile of mirtazapine

1 reference

12 December 2020

Treatment of methamphetamine use disorders: an update

1 reference

12 December 2020